Percutaneous deep vein arterialization

PROCEDURE2 trials

Sponsors

LimFlow SA

Conditions

Critical Limb Ischemia

Unknown Phase

PROMISE International

CompletedNCT03321552

LimFlow SACritical Limb Ischemia

Start: 2017-12-15End: 2025-01-23Updated: 2026-01-07

Percutaneous Deep Vein Arterialization Post-Market Study

CompletedNCT03807661

LimFlow SACritical Limb Ischemia

Start: 2019-12-11End: 2024-10-28Updated: 2026-01-16

Related Papers

PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient

CVIR Endovascular2019-07-3114 citations